AGER and endothelial dysfunction: We hypothesized that treatment with spironolactone in a 5/6 nephrectomy renal failure rat model could ameliorate endothelial dysfunction, and that the beneficial effect of spironolactone may involving inhibition of the AGEs/Receptor for AGEs (RAGE) axis and attenuation of cellular oxidative stress.